MAY 24, 2021 7:00 AM PDT

Discovery of Viral Peptides Paves the Way for Cheaper, More Accurate COVID Diagnostics

WRITTEN BY: Tara Fernandez

Over 1.5 billion vaccine doses have been administered worldwide, but SARS-CoV-2 variants are now threatening efforts to loosen the pandemic’s grip on global communities. With variants on the move from the countries they were first identified in, effective, widely available COVID diagnostics are our best hope for limiting the spread of the virus.

Serology tests are diagnostics that pick up the presence of antibodies against SARS-CoV-2 viral proteins in a patient’s blood sample. There are around 200 commercially available serology tests for COVID, most of which boast high specificities and sensitivities, and can produce results rapidly. The tests use purified viral proteins to “pull” down any antibodies against SARS-CoV-2 in the sample, creating a positive result.

However, because SARS-CoV-2 shares many molecular characteristics with other coronaviruses, there is a chance that antibodies against related viruses may create false-positive results. Additionally, the recombinant proteins used in these tests are costly to mass-produce.

In the hunt for sensitive, more cost-effective diagnostic tests, researchers have identified a series of viral peptides that bind specifically to antibodies in the plasma of patients with COVID-19. Antibodies from patients who had recovered from other coronavirus infections, common colds, as well as healthy donors were not recognized by the panel of four peptides, highlighting their specificity to SARS-CoV-2.

In this breakthrough result, the researchers showed that a unique combination of four viral peptides could be used to create a new and improved COVID diagnostic with 100 percent specificity at just a fraction of the manufacturing costs of currently available tests. Peptide epitopes are just fragments of whole proteins, slashing the costs and complexity of the manufacturing process. Additionally, using peptides reduces the risk of cross-reactivity that results in false positives.

The researchers also found an additional utility of their peptide panel—for gauging the severity of COVID symptoms. Blood samples containing high levels of antibodies against the four peptides were more likely to come from ICU patients or those requiring ventilation.

“The flexibility of these epitopes to be used alone or in combination will allow for the development of improved point-of-care-tests (POCTs),” wrote the authors.

 

Source: The Lancet.




 

About the Author
  • Tara Fernandez has a PhD in Cell Biology and has spent over a decade uncovering the molecular basis of diseases ranging from skin cancer to obesity and diabetes. She currently works on developing and marketing disruptive new technologies in the biotechnology industry. Her areas of interest include innovation in molecular diagnostics, cell therapies, and immunology. She actively participates in various science communication and public engagement initiatives to promote STEM in the community.
You May Also Like
JAN 26, 2021
Cell & Molecular Biology
Diagnostic Tool Could ID 20% of Autism Cases
JAN 26, 2021
Diagnostic Tool Could ID 20% of Autism Cases
Scientists may have created a diagnostic test that can identify as many as one-fifth of potential autism spectrum disord ...
FEB 09, 2021
Cardiology
Iron Levels as a Prognostic Indicator for Heart Failure
FEB 09, 2021
Iron Levels as a Prognostic Indicator for Heart Failure
When people think of iron, it usually brings up images of big hunks of metal. But did you know it is also essential for ...
FEB 11, 2021
Clinical & Molecular DX
Seeing if Hormone Therapy Will Work for Breast Cancer Patients
FEB 11, 2021
Seeing if Hormone Therapy Will Work for Breast Cancer Patients
Only around half of women diagnosed with breast cancer will benefit from hormonal therapy, a cancer treatment that adds, ...
MAR 25, 2021
Cardiology
Improved Triage Method to Get STEMI Patients from Door to Treatment
MAR 25, 2021
Improved Triage Method to Get STEMI Patients from Door to Treatment
A heart attack is an incredibly sudden and dangerous cardiac event that requires quick action for a successful recovery. ...
APR 20, 2021
Cardiology
Does Impaired Glucose Tolerance Increase Heart Damage After a Stroke?
APR 20, 2021
Does Impaired Glucose Tolerance Increase Heart Damage After a Stroke?
Diabetes is a looming threat to the world’s healthcare systems. Diagnoses of its precursors, impaired glucose tole ...
JUN 04, 2021
Clinical & Molecular DX
Tiny Bone Marrow Models Help Tailor Treatments for Platelet Disorder Patients
JUN 04, 2021
Tiny Bone Marrow Models Help Tailor Treatments for Platelet Disorder Patients
  Scientists have developed miniaturized 3-dimensional bone marrow models that could help physicians to predict whi ...
Loading Comments...